{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:06:26Z","timestamp":1789913186548,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.semarthrit.2011.05.005","type":"journal-article","created":{"date-parts":[[2011,8,22]],"date-time":"2011-08-22T02:04:15Z","timestamp":1313978655000},"page":"503-510","source":"Crossref","is-referenced-by-count":126,"title":["New Onset of Uveitis During Anti-Tumor Necrosis Factor Treatment for Rheumatic Diseases"],"prefix":"10.1016","volume":"41","author":[{"given":"Daniel","family":"Wendling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Paccou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Berthelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9-Marc","family":"Flipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Guillaume-Czitrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Prati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Dernis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Direz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Ferrazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Ristori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.semarthrit.2011.05.005_bib1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/ard.2007.075754","article-title":"Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review","volume":"67","author":"Zeboulon","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.05.005_bib2","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0161-6420(01)00773-4","article-title":"Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study","volume":"108","author":"Kotaniemi","year":"2001","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.semarthrit.2011.05.005_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bjo.2006.103721","article-title":"Adalimumab in the therapy of uveitis in childhood","volume":"91","author":"Biester","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.semarthrit.2011.05.005_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/09273940903072443","article-title":"Clinical review: Anti-TNFalpha therapies in uveitis: perspective on 5 years of clinical experience","volume":"17","author":"Sharma","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"10.1016\/j.semarthrit.2011.05.005_bib5","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/ard.2006.052092","article-title":"Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study","volume":"65","author":"Guignard","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2011.05.005_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cyto.2005.12.012","article-title":"Anti-TNF therapies in the management of acute and chronic uveitis","volume":"33","author":"Hale","year":"2006","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.semarthrit.2011.05.005_bib7","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/rheumatology\/kel030","article-title":"Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis","volume":"45","author":"Saurenmann","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.semarthrit.2011.05.005_bib8","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/art.21197","article-title":"Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept","volume":"52","author":"Braun","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2011.05.005_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/ard.2008.103192","article-title":"Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials","volume":"69","author":"Sieper","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2011.05.005_bib10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.2008.092585","article-title":"Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2011.05.005_bib11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/rheumatology\/ken091","article-title":"Do TNF-blockers reduce or induce uveitis?","volume":"47","author":"Cobo-Ib\u00e1\u00f1ez","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.semarthrit.2011.05.005_bib12","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis?","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2011.05.005_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/rheumatology\/kep083","article-title":"Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study","volume":"48","author":"Fouache","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.semarthrit.2011.05.005_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09273940600659393","article-title":"Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature","volume":"14","author":"Taban","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.semarthrit.2011.05.005_bib15","first-page":"838","article-title":"Etanercept therapy-associated acute uveitis: a case report and literature review","volume":"27","author":"Wang","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2011.05.005_bib16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2006.08.044","article-title":"Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents","volume":"149","author":"Saurenmann","year":"2006","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.semarthrit.2011.05.005_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3109\/02713683.2010.486520","article-title":"Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis?","volume":"35","author":"Kakkassery","year":"2010","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.semarthrit.2011.05.005_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5","article-title":"Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease","volume":"45","author":"Smith","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2011.05.005_bib19","first-page":"2727","article-title":"Ocular inflammatory disease in patients with RA taking etanercept: is discontinuation of etanercept necessary?","volume":"30","author":"Tiliakos","year":"2003","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2011.05.005_bib20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/ard.2007.077370","article-title":"Uveitis and tumour necrosis factor blockade in ankylosing spondylitis","volume":"67","author":"Coates","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2011.05.005_bib21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/bjo.87.7.925","article-title":"Does etanercept induce uveitis?","volume":"87","author":"Reddy","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.semarthrit.2011.05.005_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.62.1.88","article-title":"Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor alpha inhibitors","volume":"62","author":"Kaipiainen-Sepp\u00e4nen","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2011.05.005_bib23","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1002\/art.20754","article-title":"Effect of etanercept on iritis in patients with ankylosing spondylitis","volume":"50","author":"Rosenbaum","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.semarthrit.2011.05.005_bib24","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keh658","article-title":"Etanercept and uveitis in patients with juvenile idiopathic arthritis","volume":"44","author":"Schmeling","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.semarthrit.2011.05.005_bib25","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/art.23440","article-title":"Uveitis following the use of tumor necrosis factor alpha inhibitors: comment on the article by Lim et al","volume":"58","author":"Scrivo","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2011.05.005_bib26","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2006.04.038","article-title":"Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation","volume":"113","author":"Galor","year":"2006","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.semarthrit.2011.05.005_bib27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/09273940903521964","article-title":"Comparison of the acute effects of anti-TNF-alpha drugs on a uveitis experimental model","volume":"18","author":"Johnsen-Soriano","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2011.05.005_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09273940590909220","article-title":"Visual outcome of juvenile rheumatoid arthritis-associated uveitis in adults","volume":"13","author":"Ozdal","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.semarthrit.2011.05.005_bib29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1442-9071.2005.01062.x","article-title":"Infliximab for juvenile idiopathic arthritis-associated uveitis","volume":"33","author":"Richards","year":"2005","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.semarthrit.2011.05.005_bib30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jpeds.2006.04.058","article-title":"Adalimumab therapy for childhood uveitis","volume":"149","author":"Vazquez-Cobian","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.semarthrit.2011.05.005_bib31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/rheumatology\/kem356","article-title":"Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis","volume":"47","author":"Tynjala","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2011.05.005_bib32","first-page":"1146","article-title":"Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey","volume":"34","author":"Foeldvari","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.05.005_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.20904","article-title":"A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis","volume":"53","author":"Smith","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2011.05.005_bib34","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/ard.2006.058248","article-title":"Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis","volume":"66","author":"Tynjala","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.05.005_bib35","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/rheumatology\/kel030","article-title":"Tumour necrosis factor-a inhibitors in the treatment of childhood uveitis","volume":"45","author":"Saurenmann","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2011.05.005_bib36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ncprheum0225","article-title":"Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis","volume":"2","author":"Monnet","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.05.005_bib37","first-page":"238","article-title":"Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis","volume":"28","author":"Mart\u00edn-Mola","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2011.05.005_bib38","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/ard.2010.137422","article-title":"Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry","volume":"70","author":"Salmon-Ceron","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2011.05.005_bib39","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1136\/ard.2009.126813","article-title":"Use of TNF blockers and other targeted therapies in rare refractory immune-mediated inflammatory diseases: evidence-based or rational?","volume":"69","author":"Baeten","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017211001466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017211001466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T03:00:02Z","timestamp":1560481202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017211001466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0049017211001466"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2011.05.005","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}